We have previously shown that COX-2 expression is related to a poor prognostic phenotype of DCIS (Boland et al, 2004), but there are no published data on whether COX-2 expression affects recurrence of DCIS. The gene discussed is PTGS2; the disease is ductal breast carcinoma in situ.